US 10233222
Methods, compositions, diagnostics and assays for the treatment of Alzheimer's disease
granted A61KA61K38/00
Quick answer
US patent 10233222 (Methods, compositions, diagnostics and assays for the treatment of Alzheimer's disease) held by The Regents of the University of Colorado, a Body Corporate expires Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of Colorado, a Body Corporate
- Grant date
- Tue Mar 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K38/00